These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
||||||||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
||||||||||
|
|
|
|||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
|||||||
|
|
|
||||||||||
|
|
|
(Zip Code) | |||||||||
| (Address of principal executive offices) | |||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
||||||||||||||
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
||||||||||||||||||||
| Item Number |
Page
Number |
|||||||
|
PART I
|
||||||||
| 1. | ||||||||
| 2. | ||||||||
| 3. | ||||||||
| 4. | ||||||||
| PART II | ||||||||
| 1. | ||||||||
| 1A. | ||||||||
| 2. | ||||||||
| 6. | ||||||||
| Periods ended June 30 | Three Months |
Six Months
|
|||||||||||||||||||||
| (In millions, except per share data) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Net earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Net investment income |
|
|
|
|
|||||||||||||||||||
| Net investment gains (losses) |
|
|
|
(
|
|||||||||||||||||||
| Non-insurance warranty revenue |
|
|
|
|
|||||||||||||||||||
| Other revenues |
|
|
|
|
|||||||||||||||||||
| Total revenues |
|
|
|
|
|||||||||||||||||||
| Claims, Benefits and Expenses | |||||||||||||||||||||||
| Insurance claims and policyholders’ benefits |
|
|
|
|
|||||||||||||||||||
| Amortization of deferred acquisition costs |
|
|
|
|
|||||||||||||||||||
| Non-insurance warranty expense |
|
|
|
|
|||||||||||||||||||
| Other operating expenses |
|
|
|
|
|||||||||||||||||||
| Interest |
|
|
|
|
|||||||||||||||||||
| Total claims, benefits and expenses |
|
|
|
|
|||||||||||||||||||
| Income before income tax |
|
|
|
|
|||||||||||||||||||
| Income tax expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Comprehensive Income | |||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other Comprehensive Income (Loss), net of tax | |||||||||||||||||||||||
| Changes in: | |||||||||||||||||||||||
| Net unrealized gains and losses on investments with an allowance for credit losses |
|
|
|
(
|
|||||||||||||||||||
| Net unrealized gains and losses on other investments |
|
|
(
|
|
|||||||||||||||||||
| Net unrealized gains and losses on investments |
|
|
(
|
|
|||||||||||||||||||
| Foreign currency translation adjustment |
|
|
|
(
|
|||||||||||||||||||
| Pension and postretirement benefits |
|
|
|
|
|||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
|
(
|
|
|||||||||||||||||||
| Total comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| (In millions, except share data) | June 30, 2021 (Unaudited) | December 31, 2020 | |||||||||
| Assets | |||||||||||
| Investments: | |||||||||||
|
Fixed maturity securities at fair value (amortized cost of $
|
$ |
|
$ |
|
|||||||
|
Equity securities at fair value (cost of $
|
|
|
|||||||||
| Limited partnership investments |
|
|
|||||||||
| Other invested assets |
|
|
|||||||||
|
Mortgage loans (less allowance for uncollectible receivables of $
|
|
|
|||||||||
| Short term investments |
|
|
|||||||||
| Total investments |
|
|
|||||||||
| Cash |
|
|
|||||||||
|
Reinsurance receivables (less allowance for uncollectible receivables of $
|
|
|
|||||||||
|
Insurance receivables (less allowance for uncollectible receivables of $
|
|
|
|||||||||
| Accrued investment income |
|
|
|||||||||
| Deferred acquisition costs |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
|
Property and equipment at cost (less accumulated depreciation of $
|
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Deferred non-insurance warranty acquisition expense |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities | |||||||||||
| Insurance reserves: | |||||||||||
| Claim and claim adjustment expenses | $ |
|
$ |
|
|||||||
| Unearned premiums |
|
|
|||||||||
| Future policy benefits |
|
|
|||||||||
| Long term debt |
|
|
|||||||||
| Deferred non-insurance warranty revenue |
|
|
|||||||||
|
Other liabilities (includes $
|
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Commitments and contingencies (Notes C and F) |
|
||||||||||
| Stockholders' Equity | |||||||||||
|
Common stock ($
|
|
|
|||||||||
| Additional paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive income |
|
|
|||||||||
|
Treasury stock (
|
(
|
(
|
|||||||||
| Total stockholders’ equity |
|
|
|||||||||
| Total liabilities and stockholders' equity | $ |
|
$ |
|
|||||||
| Six months ended June 30 | |||||||||||
| (In millions) | 2021 | 2020 | |||||||||
| Cash Flows from Operating Activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash flows provided by operating activities: | |||||||||||
| Deferred income tax expense (benefit) |
|
(
|
|||||||||
| Trading portfolio activity |
|
|
|||||||||
| Net investment (gains) losses |
(
|
|
|||||||||
| Equity method investees |
(
|
|
|||||||||
| Net amortization of investments |
(
|
(
|
|||||||||
| Depreciation and amortization |
|
|
|||||||||
| Changes in: | |||||||||||
| Receivables, net |
(
|
(
|
|||||||||
| Accrued investment income |
(
|
|
|||||||||
| Deferred acquisition costs |
(
|
(
|
|||||||||
| Insurance reserves |
|
|
|||||||||
| Other, net |
(
|
(
|
|||||||||
| Net cash flows provided by operating activities |
|
|
|||||||||
| Cash Flows from Investing Activities | |||||||||||
| Dispositions: | |||||||||||
| Fixed maturity securities - sales |
|
|
|||||||||
| Fixed maturity securities - maturities, calls and redemptions |
|
|
|||||||||
| Equity securities |
|
|
|||||||||
| Limited partnerships |
|
|
|||||||||
| Mortgage loans |
|
|
|||||||||
| Purchases: | |||||||||||
| Fixed maturity securities |
(
|
(
|
|||||||||
| Equity securities |
(
|
(
|
|||||||||
| Limited partnerships |
(
|
(
|
|||||||||
| Mortgage loans |
(
|
(
|
|||||||||
| Change in other investments |
|
(
|
|||||||||
| Change in short term investments |
|
|
|||||||||
| Purchases of property and equipment |
(
|
(
|
|||||||||
| Other, net |
|
|
|||||||||
| Net cash flows (used) provided by investing activities |
(
|
|
|||||||||
| Cash Flows from Financing Activities | |||||||||||
| Dividends paid to common stockholders |
(
|
(
|
|||||||||
| Purchase of treasury stock |
(
|
(
|
|||||||||
| Other, net |
(
|
(
|
|||||||||
| Net cash flows used by financing activities |
(
|
(
|
|||||||||
| Effect of foreign exchange rate changes on cash |
|
(
|
|||||||||
| Net change in cash |
|
|
|||||||||
| Cash, beginning of year |
|
|
|||||||||
| Cash, end of period | $ |
|
$ |
|
|||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Common Stock | |||||||||||||||||||||||
| Balance, beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Balance, end of period |
|
|
|
|
|||||||||||||||||||
| Additional Paid-in Capital | |||||||||||||||||||||||
| Balance, beginning of period |
|
|
|
|
|||||||||||||||||||
| Stock-based compensation |
|
|
(
|
(
|
|||||||||||||||||||
| Balance, end of period |
|
|
|
|
|||||||||||||||||||
| Retained Earnings | |||||||||||||||||||||||
| Balance, beginning of period, as previously reported |
|
|
|
|
|||||||||||||||||||
| Cumulative effect adjustments from changes in accounting guidance, net of tax | — | — | — |
(
|
|||||||||||||||||||
| Balance, beginning of period, as adjusted |
|
|
|
|
|||||||||||||||||||
|
Dividends to common stockholders ($
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||
| Balance, end of period |
|
|
|
|
|||||||||||||||||||
| Accumulated Other Comprehensive Income | |||||||||||||||||||||||
| Balance, beginning of period |
|
(
|
|
|
|||||||||||||||||||
| Other comprehensive income (loss) |
|
|
(
|
|
|||||||||||||||||||
| Balance, end of period |
|
|
|
|
|||||||||||||||||||
| Treasury Stock | |||||||||||||||||||||||
| Balance, beginning of period |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Stock-based compensation |
|
|
|
|
|||||||||||||||||||
| Purchase of treasury stock |
(
|
— |
(
|
(
|
|||||||||||||||||||
| Balance, end of period |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total stockholders' equity | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Equity securities |
|
|
|
|
|||||||||||||||||||
| Limited partnership investments |
|
|
|
(
|
|||||||||||||||||||
| Mortgage loans |
|
|
|
|
|||||||||||||||||||
| Short term investments |
|
|
|
|
|||||||||||||||||||
| Trading portfolio |
|
|
|
|
|||||||||||||||||||
| Other |
(
|
|
|
|
|||||||||||||||||||
| Gross investment income |
|
|
|
|
|||||||||||||||||||
| Investment expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net investment income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Net investment gains (losses): | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Gross gains | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Gross losses |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net investment gains (losses) on fixed maturity securities |
|
|
|
(
|
|||||||||||||||||||
| Equity securities |
|
|
|
(
|
|||||||||||||||||||
| Derivatives |
(
|
(
|
|
(
|
|||||||||||||||||||
| Mortgage loans |
|
|
|
(
|
|||||||||||||||||||
| Short term investments and other |
|
(
|
|
(
|
|||||||||||||||||||
| Net investment gains (losses) | $ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
| Balance as of April 1, 2021 | $ |
|
$ |
|
$ |
|
|||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
| Available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities sold during the period (realized) |
|
|
|
||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis |
|
|
|
||||||||||||||
| Write-offs charged against the allowance |
|
|
|
||||||||||||||
| Recoveries of amounts previously written off |
|
|
|
||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period |
(
|
|
(
|
||||||||||||||
|
Balance as of
June 30, 2021
|
$ |
|
$ |
|
$ |
|
|||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
| Balance as of April 1, 2020 | $ |
|
$ |
|
$ |
|
|||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| For securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
| For available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities sold during the period (realized) |
|
|
|
||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis |
|
|
|
||||||||||||||
| Write-offs charged against the allowance |
|
|
|
||||||||||||||
| Recoveries of amounts previously written off |
|
|
|
||||||||||||||
|
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
|
(
|
|
(
|
||||||||||||||
|
Balance as of June 30, 2020
|
$ |
|
$ |
|
$ |
|
|||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
| Balance as of January 1, 2021 | $ |
|
$ |
|
$ |
|
|||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
| Available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities sold during the period (realized) |
|
|
|
||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis |
|
|
|
||||||||||||||
| Write-offs charged against the allowance |
|
|
|
||||||||||||||
| Recoveries of amounts previously written off |
|
|
|
||||||||||||||
| Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period |
(
|
|
(
|
||||||||||||||
|
Balance as of June 30, 2021
|
$ |
|
$ |
|
$ |
|
|||||||||||
| (In millions) | Corporate and other bonds | Asset-backed | Total | ||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
| Balance as of January 1, 2020 | $ |
|
$ |
|
$ |
|
|||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Impact of adopting ASC 326 |
|
|
|
||||||||||||||
| For securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
| For available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
| Reductions to the allowance for credit losses: | |||||||||||||||||
| Securities sold during the period (realized) |
|
|
|
||||||||||||||
| Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis |
|
|
|
||||||||||||||
| Write-offs charged against the allowance |
|
|
|
||||||||||||||
| Recoveries of amounts previously written off |
|
|
|
||||||||||||||
|
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
|
(
|
|
(
|
||||||||||||||
|
Balance as of June 30, 2020
|
$ |
|
$ |
|
$ |
|
|||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||
| Corporate and other bonds | $ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Asset-backed |
|
|
|
|
|||||||||||||||||||
| Impairment losses (gains) recognized in earnings | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| June 30, 2021 |
Cost or
Amortized Cost |
Gross
Unrealized Gains |
Gross
Unrealized Losses |
Allowance
for Credit Losses |
Estimated
Fair Value |
||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|
||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Commercial mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Other asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Total asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises |
|
|
|
|
|
||||||||||||||||||||||||
| Foreign government |
|
|
|
|
|
||||||||||||||||||||||||
| Total fixed maturity securities available-for-sale |
|
|
|
|
|
||||||||||||||||||||||||
| Total fixed maturity securities trading |
|
— | — | — |
|
||||||||||||||||||||||||
| Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| December 31, 2020 |
Cost or
Amortized Cost |
Gross
Unrealized Gains |
Gross
Unrealized Losses |
Allowance
for Credit Losses |
Estimated
Fair Value |
||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|
||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Commercial mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Other asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
| Total asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises |
|
|
|
|
|
||||||||||||||||||||||||
| Foreign government |
|
|
|
|
|
||||||||||||||||||||||||
| Total fixed maturity securities available-for-sale |
|
|
|
|
|
||||||||||||||||||||||||
| Total fixed maturity securities trading |
|
— | — | — |
|
||||||||||||||||||||||||
| Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
| June 30, 2021 |
Estimated
Fair Value |
Gross
Unrealized Losses |
Estimated
Fair Value |
Gross
Unrealized Losses |
Estimated
Fair Value |
Gross
Unrealized Losses |
|||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Commercial mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Other asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Foreign government |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
| December 31, 2020 |
Estimated
Fair Value |
Gross
Unrealized Losses |
Estimated
Fair Value |
Gross
Unrealized Losses |
Estimated
Fair Value |
Gross
Unrealized Losses |
|||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|
— | |||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Commercial mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Other asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Foreign government |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| June 30, 2021 | December 31, 2020 | ||||||||||||||||||||||
| (In millions) |
Cost or
Amortized Cost |
Estimated
Fair Value |
Cost or
Amortized Cost |
Estimated
Fair Value |
|||||||||||||||||||
| Due in one year or less | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Due after one year through five years |
|
|
|
|
|||||||||||||||||||
| Due after five years through ten years |
|
|
|
|
|||||||||||||||||||
| Due after ten years |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| June 30, 2021 |
Mortgage Loans Amortized Cost Basis by Origination Year
(1)
|
||||||||||||||||||||||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2019 | 2018 | 2017 | Prior | Total | ||||||||||||||||||||||||||||||||||
| DSCR ≥1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| DSCR 1.2x - 1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| DSCR ≤1.2 | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| June 30, 2021 |
Total
Assets/Liabilities at Fair Value |
||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|||||||||||||||||||
| Asset-backed |
|
|
|
|
|||||||||||||||||||
| Total fixed maturity securities |
|
|
|
|
|||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Common stock |
|
|
|
|
|||||||||||||||||||
| Non-redeemable preferred stock |
|
|
|
|
|||||||||||||||||||
| Total equity securities |
|
|
|
|
|||||||||||||||||||
| Short term and other |
|
|
|
|
|||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Other liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| December 31, 2020 |
Total
Assets/Liabilities at Fair Value |
||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| States, municipalities and political subdivisions |
|
|
|
|
|||||||||||||||||||
| Asset-backed |
|
|
|
|
|||||||||||||||||||
| Total fixed maturity securities |
|
|
|
|
|||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||
| Common stock |
|
|
|
|
|||||||||||||||||||
| Non-redeemable preferred stock |
|
|
|
|
|||||||||||||||||||
| Total equity securities |
|
|
|
|
|||||||||||||||||||
| Short term and other |
|
|
|
|
|||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Liabilities | |||||||||||||||||||||||
| Other liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Level 3
(In millions)
|
Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||
| Balance as of April 1, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) |
|
|
|
|
|
||||||||||||||||||||||||
| Reported in Net investment income |
|
|
|
|
|
||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) |
|
|
|
|
|
||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) |
|
|
|
|
|
||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
||||||||||||||||||||||||
| Sales |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Settlements |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
||||||||||||||||||||||||
| Transfers out of Level 3 |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2021 recognized in Net income (loss) in the period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2021 recognized in Other comprehensive income (loss) in the period |
|
|
|
|
|
||||||||||||||||||||||||
|
Level 3
(In millions)
|
Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||
| Balance as of April 1, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) |
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Reported in Net investment income |
|
|
|
|
|
||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) |
|
|
|
|
|
||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) |
|
|
|
(
|
|
||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
||||||||||||||||||||||||
| Sales |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Settlements |
(
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
||||||||||||||||||||||||
| Transfers out of Level 3 |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2020 recognized in Net income (loss) in the period | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2020 recognized in Other comprehensive income (loss) in the period |
|
|
|
|
|
||||||||||||||||||||||||
|
Level 3
(In millions)
|
Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||
| Balance as of January 1, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Reported in Net investment income |
|
|
|
|
|
||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) |
(
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) |
(
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
||||||||||||||||||||||||
| Sales |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Settlements |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
||||||||||||||||||||||||
| Transfers out of Level 3 |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2021 recognized in Net income (loss) in the period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2021 recognized in Other comprehensive income (loss) in the period |
(
|
|
(
|
|
(
|
||||||||||||||||||||||||
|
Level 3
(In millions)
|
Corporate bonds and other | States, municipalities and political subdivisions | Asset-backed | Equity securities | Total | ||||||||||||||||||||||||
| Balance as of January 1, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Total realized and unrealized investment gains (losses): | |||||||||||||||||||||||||||||
| Reported in Net investment gains (losses) |
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Reported in Net investment income |
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Reported in Other comprehensive income (loss) |
|
|
|
|
|
||||||||||||||||||||||||
| Total realized and unrealized investment gains (losses) |
|
|
|
(
|
|
||||||||||||||||||||||||
| Purchases |
|
|
|
|
|
||||||||||||||||||||||||
| Sales |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Settlements |
(
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Transfers into Level 3 |
|
|
|
|
|
||||||||||||||||||||||||
| Transfers out of Level 3 |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2020 recognized in Net income (loss) in the period | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| Unrealized gains (losses) on Level 3 assets and liabilities held as of June 30, 2020 recognized in Other comprehensive income (loss) in the period |
|
|
|
|
|
||||||||||||||||||||||||
| June 30, 2021 |
Estimated Fair Value
(In millions) |
Valuation Technique(s) | Unobservable Input(s) |
Range
(Weighted Average) |
|||||||||||||||||||
| Fixed maturity securities | $ |
|
Discounted cash flow | Credit spread |
|
||||||||||||||||||
| December 31, 2020 |
Estimated Fair Value
(In millions) |
Valuation Technique(s) | Unobservable Input(s) |
Range
(Weighted Average) |
|||||||||||||||||||
| Fixed maturity securities | $ |
|
Discounted cash flow | Credit spread |
|
||||||||||||||||||
| June 30, 2021 |
Carrying
Amount |
Estimated Fair Value | |||||||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Mortgage loans | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Long term debt | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| December 31, 2020 |
Carrying
Amount |
Estimated Fair Value | |||||||||||||||||||||||||||
| (In millions) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Mortgage loans | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Long term debt | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| For the six months ended June 30 | |||||||||||
| (In millions) | 2021 | 2020 | |||||||||
| Reserves, beginning of year: | |||||||||||
| Gross | $ |
|
$ |
|
|||||||
| Ceded |
|
|
|||||||||
| Net reserves, beginning of year |
|
|
|||||||||
| Reduction of net reserves due to Excess Workers' Compensation Loss Portfolio Transfer |
(
|
|
|||||||||
| Net incurred claim and claim adjustment expenses: | |||||||||||
| Provision for insured events of current year |
|
|
|||||||||
| Increase (decrease) in provision for insured events of prior years |
(
|
|
|||||||||
| Amortization of discount |
|
|
|||||||||
|
Total net incurred
(1)
|
|
|
|||||||||
| Net payments attributable to: | |||||||||||
| Current year events |
(
|
(
|
|||||||||
| Prior year events |
(
|
(
|
|||||||||
| Total net payments |
(
|
(
|
|||||||||
| Foreign currency translation adjustment and other |
(
|
(
|
|||||||||
| Net reserves, end of period |
|
|
|||||||||
| Ceded reserves, end of period |
|
|
|||||||||
| Gross reserves, end of period | $ |
|
$ |
|
|||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Specialty | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Commercial |
|
(
|
|
(
|
|||||||||||||||||||
| International |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Corporate & Other |
|
|
|
|
|||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Medical Professional Liability | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other Professional Liability and Management Liability |
|
(
|
|
(
|
|||||||||||||||||||
| Surety |
(
|
|
(
|
(
|
|||||||||||||||||||
| Warranty |
|
(
|
(
|
(
|
|||||||||||||||||||
| Other |
|
(
|
|
(
|
|||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Commercial Auto | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| General Liability |
|
|
|
|
|||||||||||||||||||
| Workers' Compensation |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Property and Other |
|
|
|
|
|||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Pretax (favorable) unfavorable development: | |||||||||||||||||||||||
| Casualty | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| Property, Energy and Marine |
(
|
|
(
|
|
|||||||||||||||||||
| Specialty |
|
|
|
|
|||||||||||||||||||
| Total pretax (favorable) unfavorable development | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Net periodic pension cost (benefit) | |||||||||||||||||||||||
| Interest cost on projected benefit obligation | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Amortization of net actuarial (gain) loss |
|
|
|
|
|||||||||||||||||||
| Settlement loss |
|
|
|
|
|||||||||||||||||||
| Total net periodic pension cost (benefit) | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative foreign currency translation adjustment | Total | ||||||||||||||||||||||||
| Balance as of April 1, 2021 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
|
|
|
|
|
||||||||||||||||||||||||
|
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
|
|
|
(
|
|
|
||||||||||||||||||||||||
|
Other comprehensive income (loss) net of tax (expense) benefit of $
|
|
|
|
|
|
||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative foreign currency translation adjustment | Total | ||||||||||||||||||||||||
| Balance as of April 1, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
|
(
|
|
|
||||||||||||||||||||||||
|
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
|
(
|
|
(
|
|
|
||||||||||||||||||||||||
|
Other comprehensive income (loss) net of tax (expense) benefit of $(
|
|
|
|
|
|
||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative foreign currency translation adjustment | Total | ||||||||||||||||||||||||
| Balance as of January 1, 2021 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
(
|
|
|
(
|
||||||||||||||||||||||||
|
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
|
(
|
|
(
|
|
|
||||||||||||||||||||||||
|
Other comprehensive income (loss) net of tax (expense) benefit of $
|
|
(
|
|
|
(
|
||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| (In millions) | Net unrealized gains (losses) on investments with an allowance for credit losses | Net unrealized gains (losses) on other investments | Pension and postretirement benefits | Cumulative foreign currency translation adjustment | Total | ||||||||||||||||||||||||
| Balance as of January 1, 2020 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
|
(
|
(
|
|
||||||||||||||||||||||||
|
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
|
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||
|
Other comprehensive income (loss) net of tax (expense) benefit of $
|
(
|
|
|
(
|
|
||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||
| Component of AOCI | Consolidated Statements of Operations Line Item Affected by Reclassifications | |||||||
| Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments | Net investment gains (losses) | |||||||
| Pension and postretirement benefits | Other operating expenses and Insurance claims and policyholders' benefits | |||||||
| Three months ended June 30, 2021 |
Specialty |
Commercial |
International |
Life &
Group |
Corporate
& Other |
||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Net investment income |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other revenues |
|
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total operating revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Policyholders’ dividends |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other insurance related expenses |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other expenses |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Core income (loss) before income tax |
|
|
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) |
(
|
(
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||
| Core income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|
||||||||||||||||||||||||||||
| Net investment gains (losses) |
|
||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) |
(
|
||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax |
|
||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||||||||||||||||||||||||||
| Three months ended June 30, 2020 |
Specialty |
Commercial |
International |
Life &
Group |
Corporate
& Other |
||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Net investment income |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total operating revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Policyholders’ dividends |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other insurance related expenses |
|
|
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Other expenses |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Core income (loss) before income tax |
|
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) |
(
|
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||
| Core income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|
||||||||||||||||||||||||||||
| Net investment gains (losses) |
|
||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) |
(
|
||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax |
|
||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||||||||||||||||||||||||||
| Six months ended June 30, 2021 |
Specialty |
Commercial |
International |
Life &
Group |
Corporate
& Other |
||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Net investment income |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total operating revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Policyholders’ dividends |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other insurance related expenses |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other expenses |
|
|
(
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Core income (loss) before income tax |
|
|
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) |
(
|
(
|
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||
| Core income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|
||||||||||||||||||||||||||||
| Net investment gains (losses) |
|
||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) |
(
|
||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax |
|
||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||||||||||||||||||||||||||
| June 30, 2021 | |||||||||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||
| Reinsurance receivables | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Insurance receivables |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Goodwill |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty acquisition expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Insurance reserves | |||||||||||||||||||||||||||||||||||||||||
| Claim and claim adjustment expenses |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Unearned premiums |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Future policy benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Six months ended June 30, 2020 |
Specialty |
Commercial |
International |
Life &
Group |
Corporate
& Other |
||||||||||||||||||||||||||||||||||||
| (In millions) | Eliminations | Total | |||||||||||||||||||||||||||||||||||||||
| Operating revenues | |||||||||||||||||||||||||||||||||||||||||
| Net earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Net investment income |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total operating revenues |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Claims, benefits and expenses | |||||||||||||||||||||||||||||||||||||||||
| Net incurred claims and benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Policyholders’ dividends |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other insurance related expenses |
|
|
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Other expenses |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Total claims, benefits and expenses |
|
|
|
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Core income (loss) before income tax |
|
|
(
|
(
|
(
|
|
|
||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on core income (loss) |
(
|
(
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||
| Core income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|
||||||||||||||||||||||||||||
| Net investment gains (losses) |
(
|
||||||||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) |
|
||||||||||||||||||||||||||||||||||||||||
| Net investment gains (losses), after tax |
(
|
||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ |
|
|||||||||||||||||||||||||||||||||||||||
| December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||
| Reinsurance receivables | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Insurance receivables |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred acquisition costs |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Goodwill |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty acquisition expense |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Insurance reserves | |||||||||||||||||||||||||||||||||||||||||
| Claim and claim adjustment expenses |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Unearned premiums |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Future policy benefits |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Deferred non-insurance warranty revenue |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Specialty | |||||||||||||||||||||||
| Management & Professional Liability | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Surety |
|
|
|
|
|||||||||||||||||||
| Warranty & Alternative Risks |
|
|
|
|
|||||||||||||||||||
| Specialty revenues |
|
|
|
|
|||||||||||||||||||
| Commercial | |||||||||||||||||||||||
| Middle Market |
|
|
|
|
|||||||||||||||||||
| Construction |
|
|
|
|
|||||||||||||||||||
| Small Business |
|
|
|
|
|||||||||||||||||||
| Other Commercial |
|
|
|
|
|||||||||||||||||||
| Commercial revenues |
|
|
|
|
|||||||||||||||||||
| International | |||||||||||||||||||||||
| Canada |
|
|
|
|
|||||||||||||||||||
| Europe |
|
|
|
|
|||||||||||||||||||
| Hardy |
|
|
|
|
|||||||||||||||||||
| International revenues |
|
|
|
|
|||||||||||||||||||
| Life & Group revenues |
|
|
|
|
|||||||||||||||||||
| Corporate & Other revenues |
|
|
|
|
|||||||||||||||||||
| Eliminations |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total operating revenues |
|
|
|
|
|||||||||||||||||||
| Net investment gains (losses) |
|
|
|
(
|
|||||||||||||||||||
| Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Operating Revenues | |||||||||||||||||||||||
| Net earned premiums | $ | 2,035 | $ | 1,850 | $ | 3,997 | $ | 3,719 | |||||||||||||||
| Net investment income | 591 | 534 | 1,095 | 863 | |||||||||||||||||||
| Non-insurance warranty revenue | 359 | 308 | 697 | 609 | |||||||||||||||||||
| Other revenues | 6 | 5 | 11 | 13 | |||||||||||||||||||
| Total operating revenues | 2,991 | 2,697 | 5,800 | 5,204 | |||||||||||||||||||
| Claims, Benefits and Expenses | |||||||||||||||||||||||
| Net incurred claims and benefits | 1,539 | 1,636 | 3,039 | 3,055 | |||||||||||||||||||
| Policyholders' dividends | 7 | 6 | 13 | 12 | |||||||||||||||||||
| Amortization of deferred acquisition costs | 357 | 342 | 716 | 686 | |||||||||||||||||||
| Non-insurance warranty expense | 332 | 285 | 643 | 566 | |||||||||||||||||||
| Other insurance related expenses | 271 | 260 | 526 | 518 | |||||||||||||||||||
| Other expenses | 61 | 55 | 118 | 127 | |||||||||||||||||||
| Total claims, benefits and expenses | 2,567 | 2,584 | 5,055 | 4,964 | |||||||||||||||||||
| Core income before income tax | 424 | 113 | 745 | 240 | |||||||||||||||||||
| Income tax expense on core income | (83) | (14) | (141) | (33) | |||||||||||||||||||
| Core income | 341 | 99 | 604 | 207 | |||||||||||||||||||
| Net investment gains (losses) | 38 | 69 | 95 | (147) | |||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) | (11) | (17) | (19) | 30 | |||||||||||||||||||
| Net investment gains (losses), after tax | 27 | 52 | 76 | (117) | |||||||||||||||||||
| Net income | $ | 368 | $ | 151 | $ | 680 | $ | 90 | |||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Gross written premiums | $ | 1,903 | $ | 1,762 | $ | 3,697 | $ | 3,476 | |||||||||||||||
| Gross written premiums excluding third party captives | 897 | 811 | 1,713 | 1,552 | |||||||||||||||||||
| Net written premiums | 786 | 742 | 1,528 | 1,436 | |||||||||||||||||||
| Net earned premiums | 762 | 705 | 1,497 | 1,390 | |||||||||||||||||||
| Net investment income | 134 | 133 | 251 | 189 | |||||||||||||||||||
| Core income | 188 | 90 | 358 | 186 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio excluding catastrophes and development | 59.0 | % | 59.9 | % | 59.2 | % | 59.7 | % | |||||||||||||||
| Effect of catastrophe impacts | — | 15.0 | 0.3 | 8.2 | |||||||||||||||||||
| Effect of development-related items | (1.3) | (2.9) | (1.6) | (2.3) | |||||||||||||||||||
| Loss ratio | 57.7 | 72.0 | 57.9 | 65.6 | |||||||||||||||||||
| Expense ratio | 30.0 | 32.0 | 30.2 | 32.1 | |||||||||||||||||||
| Dividend ratio | 0.2 | 0.2 | 0.2 | 0.2 | |||||||||||||||||||
| Combined ratio | 87.9 | % | 104.2 | % | 88.3 | % | 97.9 | % | |||||||||||||||
| Combined ratio excluding catastrophes and development | 89.2 | % | 92.1 | % | 89.6 | % | 92.0 | % | |||||||||||||||
| Rate | 11 | % | 12 | % | 11 | % | 11 | % | |||||||||||||||
| Renewal premium change | 10 | 13 | 10 | 12 | |||||||||||||||||||
| Retention | 85 | 86 | 86 | 85 | |||||||||||||||||||
| New business | $ | 121 | $ | 96 | $ | 224 | $ | 170 | |||||||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | |||||||||
| Gross case reserves | $ | 1,526 | $ | 1,567 | |||||||
| Gross IBNR reserves | 4,652 | 4,181 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 6,178 | $ | 5,748 | |||||||
| Net case reserves | $ | 1,360 | $ | 1,410 | |||||||
| Net IBNR reserves | 3,762 | 3,488 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 5,122 | $ | 4,898 | |||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Gross written premiums | $ | 1,161 | $ | 1,126 | $ | 2,274 | $ | 2,188 | |||||||||||||||
| Gross written premiums excluding third party captives | 1,060 | 1,044 | 2,171 | 2,103 | |||||||||||||||||||
| Net written premiums | 831 | 949 | 1,791 | 1,899 | |||||||||||||||||||
| Net earned premiums | 881 | 795 | 1,736 | 1,613 | |||||||||||||||||||
| Net investment income | 174 | 161 | 322 | 203 | |||||||||||||||||||
| Core income | 137 | 49 | 206 | 72 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio excluding catastrophes and development | 60.1 | % | 58.7 | % | 60.4 | % | 59.7 | % | |||||||||||||||
| Effect of catastrophe impacts | 5.8 | 19.0 | 9.6 | 12.8 | |||||||||||||||||||
| Effect of development-related items | 0.8 | (0.3) | 0.7 | (0.1) | |||||||||||||||||||
| Loss ratio | 66.7 | 77.4 | 70.7 | 72.4 | |||||||||||||||||||
| Expense ratio | 32.3 | 33.9 | 31.8 | 33.6 | |||||||||||||||||||
| Dividend ratio | 0.6 | 0.6 | 0.6 | 0.6 | |||||||||||||||||||
| Combined ratio | 99.6 | % | 111.9 | % | 103.1 | % | 106.6 | % | |||||||||||||||
| Combined ratio excluding catastrophes and development | 93.0 | % | 93.2 | % | 92.8 | % | 93.9 | % | |||||||||||||||
| Rate | 8 | % | 10 | % | 9 | % | 9 | % | |||||||||||||||
| Renewal premium change | 10 | 9 | 9 | 9 | |||||||||||||||||||
| Retention | 81 | 84 | 82 | 85 | |||||||||||||||||||
| New business | $ | 201 | $ | 198 | $ | 412 | $ | 396 | |||||||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | |||||||||
| Gross case reserves | $ | 3,249 | $ | 3,215 | |||||||
| Gross IBNR reserves | 5,284 | 5,035 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 8,533 | $ | 8,250 | |||||||
| Net case reserves | $ | 2,935 | $ | 2,885 | |||||||
| Net IBNR reserves | 4,871 | 4,590 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 7,806 | $ | 7,475 | |||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions, except ratios, rate, renewal premium change and retention) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Gross written premiums | $ | 339 | $ | 277 | $ | 682 | $ | 584 | |||||||||||||||
| Net written premiums | 292 | 239 | 527 | 458 | |||||||||||||||||||
| Net earned premiums | 266 | 224 | 518 | 463 | |||||||||||||||||||
| Net investment income | 14 | 14 | 28 | 29 | |||||||||||||||||||
| Core income (loss) | 26 | (14) | 50 | (12) | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio excluding catastrophes and development | 59.0 | % | 59.9 | % | 59.3 | % | 60.1 | % | |||||||||||||||
| Effect of catastrophe impacts | 0.8 | 19.9 | 1.4 | 11.9 | |||||||||||||||||||
| Effect of development-related items | (0.3) | (1.2) | (0.2) | (0.7) | |||||||||||||||||||
| Loss ratio | 59.5 | 78.6 | 60.5 | 71.3 | |||||||||||||||||||
| Expense ratio | 33.5 | 36.7 | 33.9 | 36.1 | |||||||||||||||||||
| Combined ratio | 93.0 | % | 115.3 | % | 94.4 | % | 107.4 | % | |||||||||||||||
| Combined ratio excluding catastrophes and development | 92.5 | % | 96.6 | % | 93.2 | % | 96.2 | % | |||||||||||||||
| Rate | 13 | % | 15 | % | 13 | % | 12 | % | |||||||||||||||
| Renewal premium change | 14 | 10 | 13 | 9 | |||||||||||||||||||
| Retention | 77 | 74 | 75 | 72 | |||||||||||||||||||
| New business | $ | 71 | $ | 62 | $ | 150 | $ | 130 | |||||||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | |||||||||
| Gross case reserves | $ | 881 | $ | 892 | |||||||
| Gross IBNR reserves | 1,344 | 1,199 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 2,225 | $ | 2,091 | |||||||
| Net case reserves | $ | 765 | $ | 777 | |||||||
| Net IBNR reserves | 1,141 | 1,045 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 1,906 | $ | 1,822 | |||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Net earned premiums | $ | 126 | $ | 126 | $ | 246 | $ | 253 | |||||||||||||||
| Net investment income | 265 | 206 | 484 | 414 | |||||||||||||||||||
| Core income (loss) before income tax | 41 | 3 | 73 | (7) | |||||||||||||||||||
| Income tax benefit on core loss | 2 | 11 | 6 | 25 | |||||||||||||||||||
| Core income | 43 | 14 | 79 | 18 | |||||||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Net investment income | $ | 4 | $ | 20 | $ | 10 | $ | 28 | |||||||||||||||
| Interest expense | 28 | 31 | 56 | 62 | |||||||||||||||||||
| Core loss | (53) | (40) | (89) | (57) | |||||||||||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | |||||||||
| Gross case reserves | $ | 1,601 | $ | 1,614 | |||||||
| Gross IBNR reserves | 1,189 | 1,260 | |||||||||
| Total gross carried claim and claim adjustment expense reserves | $ | 2,790 | $ | 2,874 | |||||||
| Net case reserves | $ | 134 | $ | 560 | |||||||
| Net IBNR reserves | 146 | 331 | |||||||||
| Total net carried claim and claim adjustment expense reserves | $ | 280 | $ | 891 | |||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Fixed income securities: | |||||||||||||||||||||||
| Taxable fixed income securities | $ | 356 | $ | 360 | $ | 715 | $ | 731 | |||||||||||||||
| Tax-exempt fixed income securities | 79 | 80 | 159 | 158 | |||||||||||||||||||
| Total fixed income securities | 435 | 440 | 874 | 889 | |||||||||||||||||||
| Limited partnership and common stock investments | 156 | 84 | 217 | (41) | |||||||||||||||||||
| Other, net of investment expense | — | 10 | 4 | 15 | |||||||||||||||||||
| Net investment income | $ | 591 | $ | 534 | $ | 1,095 | $ | 863 | |||||||||||||||
| Effective income yield for the fixed income securities portfolio | 4.3 | % | 4.6 | % | 4.4 | % | 4.6 | % | |||||||||||||||
| Limited partnership and common stock return | 8.3 | % | 5.0 | % | 12.1 | % | (2.3) | % | |||||||||||||||
| Periods ended June 30 | Three Months | Six Months | |||||||||||||||||||||
| (In millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate and other bonds | $ | 43 | $ | (40) | $ | 79 | $ | (119) | |||||||||||||||
| States, municipalities and political subdivisions | — | 33 | (1) | 33 | |||||||||||||||||||
| Asset-backed | (12) | 24 | (9) | 28 | |||||||||||||||||||
| Total fixed maturity securities | 31 | 17 | 69 | (58) | |||||||||||||||||||
| Non-redeemable preferred stock | 17 | 63 | 19 | (70) | |||||||||||||||||||
| Short term and other | (10) | (11) | 7 | (6) | |||||||||||||||||||
| Mortgage loans | — | — | — | (13) | |||||||||||||||||||
| Net investment gains (losses) | 38 | 69 | 95 | (147) | |||||||||||||||||||
| Income tax (expense) benefit on net investment gains (losses) |
(
|
(17) |
(
|
30 | |||||||||||||||||||
| Net investment gains (losses), after tax | $ | 27 | $ | 52 | $ | 76 | $ | (117) | |||||||||||||||
| June 30, 2021 | December 31, 2020 | ||||||||||||||||||||||
|
(In millions) |
Estimated Fair Value | Net Unrealized Gains (Losses) | Estimated Fair Value | Net Unrealized Gains (Losses) | |||||||||||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 3,162 | $ | 59 | $ | 3,672 | $ | 117 | |||||||||||||||
| AAA | 3,866 | 408 | 3,627 | 454 | |||||||||||||||||||
| AA | 7,458 | 920 | 7,159 | 1,012 | |||||||||||||||||||
| A | 9,440 | 1,219 | 9,543 | 1,390 | |||||||||||||||||||
| BBB | 18,558 | 2,376 | 18,007 | 2,596 | |||||||||||||||||||
| Non-investment grade | 2,426 | 147 | 2,623 | 149 | |||||||||||||||||||
| Total | $ | 44,910 | $ | 5,129 | $ | 44,631 | $ | 5,718 | |||||||||||||||
| June 30, 2021 | |||||||||||
| (In millions) | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 937 | $ | 15 | |||||||
| AAA | 171 | 1 | |||||||||
| AA | 291 | 6 | |||||||||
| A | 726 | 14 | |||||||||
| BBB | 685 | 22 | |||||||||
| Non-investment grade | 327 | 12 | |||||||||
| Total | $ | 3,137 | $ | 70 | |||||||
| June 30, 2021 | |||||||||||
| (In millions) | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| Due in one year or less | $ | 151 | $ | 5 | |||||||
| Due after one year through five years | 515 | 17 | |||||||||
| Due after five years through ten years | 1,800 | 30 | |||||||||
| Due after ten years | 671 | 18 | |||||||||
| Total | $ | 3,137 | $ | 70 | |||||||
| June 30, 2021 | December 31, 2020 | ||||||||||||||||||||||
| (In millions) | Estimated Fair Value |
Effective
Duration (In years) |
Estimated Fair Value |
Effective
Duration (In years) |
|||||||||||||||||||
| Investments supporting Life & Group | $ | 18,551 | 9.3 | $ | 18,518 | 9.2 | |||||||||||||||||
| Other investments | 28,540 | 4.9 | 28,839 | 4.5 | |||||||||||||||||||
| Total | $ | 47,091 | 6.6 | $ | 47,357 | 6.3 | |||||||||||||||||
| (In millions) | June 30, 2021 | December 31, 2020 | |||||||||
| Short term investments: | |||||||||||
| U.S. Treasury securities | $ | 1,228 | $ | 1,702 | |||||||
| Other | 237 | 205 | |||||||||
| Total short term investments | $ | 1,465 | $ | 1,907 | |||||||
| Period | (a) Total number of shares purchased | (b) Average price paid per share | (c) Total number of shares purchased as part of publicly announced plans or programs | (d) Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs (in millions) | |||||||||||||||||||||||||||||||
| May 1, 2021 - May 31, 2021 | 194,736 | $ | 47.45 | N/A | N/A | ||||||||||||||||||||||||||||||
| June 1, 2021 - June 30, 2021 | 116,879 | $ | 47.77 | N/A | N/A | ||||||||||||||||||||||||||||||
| Total | 311,615 | N/A | N/A | ||||||||||||||||||||||||||||||||
| CNA Financial Corporation | ||||||||
| Dated: August 2, 2021 | By | /s/ Albert J. Miralles | ||||||
|
Albert J. Miralles
Executive Vice President and Chief Financial Officer (Duly authorized officer and principal financial and accounting officer) |
||||||||
| Description of Exhibit | Exhibit Number | ||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1 | |||||
| 32.2 | |||||
| XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | 101.INS | ||||
| Inline XBRL Taxonomy Extension Schema | 101.SCH | ||||
| Inline XBRL Taxonomy Extension Calculation Linkbase | 101.CAL | ||||
| Inline XBRL Taxonomy Extension Definition Linkbase | 101.DEF | ||||
| Inline XBRL Taxonomy Label Linkbase | 101.LAB | ||||
| Inline XBRL Taxonomy Extension Presentation Linkbase | 101.PRE | ||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | 104.1 | ||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|